Ann C. Miller

Insider Reports History

Entity
Individual
Location
C/O Inovio Pharmaceuticals, Inc., 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA
Signature
/s/ Ann C. Miller
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ann C. Miller:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PUMA BIOTECHNOLOGY, INC. Director COMMON STOCK 40.7K $183K $4.49 Jun 15, 2021 Direct
INOVIO PHARMACEUTICALS, INC. Director Common Stock 7.71K $101K $13.07 May 15, 2024 Direct
INOVIO PHARMACEUTICALS, INC. Director Restricted Stock Unit 2.17K $28.3K $13.07 May 21, 2024 Direct
Allena Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 37K Jun 3, 2021 Direct
INOVIO PHARMACEUTICALS, INC. Director Common Stock Options 2.92K May 21, 2024 Direct

Insider Reports Filed by Ann C. Miller

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INO INOVIO PHARMACEUTICALS, INC. May 21, 2024 2 $0 4 May 22, 2024 Director
INO INOVIO PHARMACEUTICALS, INC. May 15, 2024 2 $0 4 May 16, 2024 Director
INO INOVIO PHARMACEUTICALS, INC. May 15, 2023 4 $0 4 May 16, 2023 Director
INO INOVIO PHARMACEUTICALS, INC. May 13, 2022 4 $0 4 May 17, 2022 Director
INO INOVIO PHARMACEUTICALS, INC. Mar 21, 2022 2 $0 4 Mar 22, 2022 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 10, 2021 1 -$147K 4 Jun 11, 2021 Director
ALNAQ Allena Pharmaceuticals, Inc. Jun 3, 2021 1 $0 4 Jun 4, 2021 Director
INO INOVIO PHARMACEUTICALS, INC. May 13, 2021 4 $0 4 May 17, 2021 Director